Plant ID: NPO30530
Plant Latin Name: Cimicifuga dahurica
Taxonomy Genus: Actaea
Taxonomy Family: Ranunculaceae
NCBI TaxonomyDB:
n.a.
Plant-of-the-World-Online:
n.a.
Analgesic; Antibacterial; Antiviral; Depurative; Diaphoretic; Diuretic; Febrifuge; Sedative; Tonic
China
PTPN1; | |
TDP1; HSD17B10; | |
MAPK1; | |
CA2; CA14; CA7; CA6; CA12; CA1; CA9; CA5B; CA3; CA5A; | |
MMP2; MMP9; MMP1; | |
NFKB1; | |
LMNA; |
Cytochrome P450 Enzymes: | CYP3A4; |
---|
Protein Class | Gene ID | Protein Name | Uniprot ID | Target ChEMBL ID |
---|---|---|---|---|
Cytochrome P450 family 3 | CYP3A4 | Cytochrome P450 3A4 | P08684 | CHEMBL340 |
Enzyme_unclassified | TDP1 | Tyrosyl-DNA phosphodiesterase 1 | Q9NUW8 | CHEMBL1075138 |
Enzyme_unclassified | HSD17B10 | Endoplasmic reticulum-associated amyloid beta-peptide-binding protein | Q99714 | CHEMBL4159 |
Lyase | CA2 | Carbonic anhydrase II | P00918 | CHEMBL205 |
Lyase | CA14 | Carbonic anhydrase XIV | Q9ULX7 | CHEMBL3510 |
Lyase | CA7 | Carbonic anhydrase VII | P43166 | CHEMBL2326 |
Lyase | CA6 | Carbonic anhydrase VI | P23280 | CHEMBL3025 |
Lyase | CA12 | Carbonic anhydrase XII | O43570 | CHEMBL3242 |
Lyase | CA1 | Carbonic anhydrase I | P00915 | CHEMBL261 |
Lyase | CA9 | Carbonic anhydrase IX | Q16790 | CHEMBL3594 |
Lyase | CA5B | Carbonic anhydrase VB | Q9Y2D0 | CHEMBL3969 |
Lyase | CA3 | Carbonic anhydrase III | P07451 | CHEMBL2885 |
Lyase | CA5A | Carbonic anhydrase VA | P35218 | CHEMBL4789 |
Metallo protease | MMP2 | Matrix metalloproteinase-2 | P08253 | CHEMBL333 |
Metallo protease | MMP9 | Matrix metalloproteinase 9 | P14780 | CHEMBL321 |
Metallo protease | MMP1 | Matrix metalloproteinase-1 | P03956 | CHEMBL332 |
Protein Kinase | MAPK1 | MAP kinase ERK2 | P28482 | CHEMBL4040 |
Protein Phosphatase | PTPN1 | Protein-tyrosine phosphatase 1B | P18031 | CHEMBL335 |
Transcription Factor | NFKB1 | Nuclear factor NF-kappa-B p105 subunit | P19838 | CHEMBL3251 |
Unclassified | LMNA | Prelamin-A/C | P02545 | CHEMBL1293235 |
GO Type | GO Category | Enriched GO Terms | p-Value | Adjusted p-Value | Enriched Genes |
---|---|---|---|---|---|
MF | GO:0005488; binding | GO:0008270; zinc ion binding | 6.987E-14 | 1.902E-10 | CA1, CA12, CA2, CA3, CA5A, CA5B, CA6, CA7, CA9, MMP1, MMP2, MMP9, PTPN1 |
MF | GO:0003824; catalytic activity | GO:0004089; carbonate dehydratase activity | 2.784E-28 | 6.063E-24 | CA1, CA12, CA14, CA2, CA3, CA5A, CA5B, CA6, CA7, CA9 |
BP | GO:0009987; cellular process | GO:0032849; positive regulation of cellular pH reduction | 3.054E-06 | 3.911E-03 | CA2, CA7 |
BP | GO:0051179; localization | GO:0015701; bicarbonate transport | 2.269E-22 | 2.471E-18 | CA1, CA12, CA14, CA2, CA3, CA5A, CA5B, CA6, CA7, CA9 |
BP | GO:0008152; metabolic process | GO:0006730; one-carbon metabolic process | 1.515E-20 | 8.245E-17 | CA1, CA12, CA2, CA3, CA5A, CA5B, CA6, CA7, CA9 |
MF | GO:0003824; catalytic activity | GO:0004064; arylesterase activity | 1.524E-05 | 1.508E-02 | CA1, CA2 |
BP | GO:0008152; metabolic process | GO:0030574; collagen catabolic process | 3.980E-05 | 3.611E-02 | MMP1, MMP2, MMP9 |
BP | GO:0051179; localization | GO:2001225; regulation of chloride transport | 4.561E-05 | 3.972E-02 | CA2, CA7 |
Pathway Category Top Level | Pathway Category Second Level | Pathway ID | Pathway Name | p-Value | Adjusted p-Value | Enriched Genes |
---|---|---|---|---|---|---|
09100 Metabolism | 09102 Energy metabolism | hsa00910 | Nitrogen metabolism | 1.272E-27 | 1.590E-25 | CA12, CA1, CA3, CA5B, CA2, CA5A, CA7, CA6, CA9, CA14 |
09160 Human Diseases | 09161 Cancers | hsa05219 | Bladder cancer | 7.190E-08 | 4.493E-06 | MMP1, MMP2, MAPK1, MMP9 |
09160 Human Diseases | 09161 Cancers | hsa05200 | Pathways in cancer | 3.643E-05 | 1.518E-03 | MMP1, MMP2, MAPK1, MMP9, NFKB1 |
09160 Human Diseases | 09166 Endocrine and metabolic diseases | hsa04933 | AGE-RAGE signaling pathway in diabetic complications | 1.339E-04 | 3.347E-03 | MMP2, MAPK1, NFKB1 |
09150 Organismal Systems | 09152 Endocrine system | hsa04915 | Estrogen signaling pathway | 1.262E-04 | 3.347E-03 | MMP2, MAPK1, MMP9 |
09130 Environmental Information Processing | 09132 Signal transduction | hsa04668 | TNF signaling pathway | 1.724E-04 | 3.591E-03 | MAPK1, MMP9, NFKB1 |
09140 Cellular Processes | 09143 Cell growth and death | hsa04210 | Apoptosis | 3.507E-04 | 6.197E-03 | LMNA, MAPK1, NFKB1 |
09160 Human Diseases | 09167 Infectious diseases | hsa05161 | Hepatitis B | 3.966E-04 | 6.197E-03 | MAPK1, MMP9, NFKB1 |
09160 Human Diseases | 09161 Cancers | hsa05205 | Proteoglycans in cancer | 1.034E-03 | 1.436E-02 | MMP2, MAPK1, MMP9 |
09160 Human Diseases | 09167 Infectious diseases | hsa05131 | Shigellosis | 1.903E-03 | 1.577E-02 | MAPK1, NFKB1 |
ICD10 Disease Category | Disease Name | ICD10 Code | Associated Disease Targets (Association Ref: TTD database) |
---|---|---|---|
C00-D49: Neoplasms | Colorectal cancer | C18-C21 | MMP9; |
C00-D49: Neoplasms | Solid tumours | C00-D48 | MMP9; MMP2; |
C00-D49: Neoplasms | Non-small-cell lung cancer | NA | MMP2; |
I00-I99: Diseases of the circulatory system | Stroke | I61-I63, I80-I82 | MMP9; |
M00-M99: Diseases of the musculoskeletal system and connective tissue | Arthritis | M00-M25 | MMP1; |
C00-D49: Neoplasms | Cancer | C00-C96 | NFKB1; MMP9; MMP2; |
M00-M99: Diseases of the musculoskeletal system and connective tissue | Osteoarthritis | M15-M19, M47 | MMP2; |
L00-L99: Diseases of the skin and subcutaneous tissue | Acne vulgaris | L70.0 | MMP2; |
M00-M99: Diseases of the musculoskeletal system and connective tissue | Rheumatoid arthritis | M05-M06 | MMP1; |
E00-E89: Endocrine, nutritional and metabolic diseases | Diabetic nephropathy | E11.21 | MMP1; |
K00-K95: Diseases of the digestive system | Ulcerative colitis | K51 | MMP9; |
C00-D49: Neoplasms | Pancreatic cancer | C25 | MMP2; |
C00-D49: Neoplasms | Renal cell carcinoma | NA | MMP2; |
E00-E89: Endocrine, nutritional and metabolic diseases | Type 2 diabetes | E11 | NFKB1; |
C00-D49: Neoplasms | Ovarian cancer | C56 | MMP2; |
C00-D49: Neoplasms | Lung cancer | C33-C34 | MMP2; |